Clinical Trials in Los Angeles

Showing 2301-2320 of 8,055 trials

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

NCT02781883

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission \[CR\], Complete Remission with incomplete hematologic recovery \[CRi\], Complete Remission with partial hematologic recovery \[CRh\], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (CR, CRi, CRh) than intensive chemotherapy (by historical comparison) in participants with refractory/relapsed AML.

Acute Myeloid Leukemia (AML)

Bio-Path Holdings, Inc.108 participantsStarted May 2016

Los Angeles, California, United States • Augusta, Georgia, United States • Fairway, Kansas, United States +6 more locations

COMPLETEDPhase 2< 1 mile

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

NCT01536886

The purpose of this study is to investigate whether LEO 90100 and calcipotriol plus betamethasone are effective in the treatment of psoriasis vulgaris.

Psoriasis Vulgaris

LEO Pharma376 participantsStarted May 2012

Hot Springs, Arkansas, United States • Los Angeles, California, United States • Oceanside, California, United States +36 more locations

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Find Trials by Condition in Los Angeles

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Trial of DFP-14927 in Advanced Solid Tumors

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Study of LP-184 in Patients With Advanced Solid Tumors

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice